IMMUNGLOBULIN

✅ No active alerts 11 total alerts on record

✅

All clear right now

No active EU-wide shortages or safety letters for this substance. National-level issues may still exist.

📈 Alert history (last 10 years)

📚 Past alerts (11)

Low AT resolved 4 years ago

IQYMUNE 100 mg/ml Infusionslösung 100 mg/ml (Infusionslösung)

Parallel export of IQYMUNE 100 mg/ml infusion solution is banned. Supply shortages in production mean domestic patient needs cannot be met, despite no distribution restrictions from the marketing auth...

Low AT resolved 5 years ago

Octagam 100 mg/ml Infusionslösung 100 mg/ml (Infusionslösung)

Octagam 100 mg/ml infusion solution is subject to a parallel export ban due to active ingredient shortages. Supply for domestic patients cannot be met despite no distribution restrictions from the mar...

Low AT resolved 5 years ago

Octagam 5% Infusionslösung 5 % (Infusionslösung)

Export of this medicine is restricted due to limited supply. Supplies are reserved for domestic patients. Do not attempt to obtain or distribute this product outside the country.

Low AT resolved 5 years ago

GAMMAGARD S/D Pulver und Lösungsmittel zur Herstellung einer Infusionslösung (Pulver und Lösungsmittel zur Herstellung einer Infusionslösung)

Gammagard S/D powder and solvent for infusion solution (powder and solvent for preparing an infusion solution) is subject to a parallel export ban.

Low AT resolved 5 years ago

Cuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung 200 mg/ml (Injektionslösung)

Cuvitru 200 mg/ml injection solution for subcutaneous use is subject to a parallel export ban due to active ingredient shortages.

Low AT resolved 5 years ago

Intratect 100 g/l Infusionslösung 100 g/l (Infusionslösung)

Parallel export of Intratect 100 g/l infusion solution is banned due to active ingredient shortages. The medicine is authorised by Biotest Pharma GmbH in Germany. Supplies are limited to what is neede...

Low AT resolved 5 years ago

Intratect 50 g/l Infusionslösung 50 g/l (Infusionslösung)

Parallel export ban in effect for Intratect 50 g/l infusion solution due to active ingredient shortage.

Low AT resolved 5 years ago

Ig Vena 50 g/l Infusionslösung 50 g/l (Infusionslösung)

Parallel export ban active for Ig Vena 50 g/l Infusionslösung.

Low AT resolved 5 years ago

HyQvia 100 mg/ml Infusionslösung zur subkutanen Anwendung 100 mg/ml (Infusionslösung)

HyQvia 100 mg/ml infusion solution for subcutaneous use is subject to a parallel export ban due to active ingredient shortages.

Low AT resolved 5 years ago

Privigen 100 mg/ml Infusionslösung 100 mg/ml (Infusionslösung)

Parallel export ban active for Privigen 100 mg/ml infusion solution. Supply is limited due to active ingredient shortage. Patient needs within Germany cannot be met despite full distribution capabilit...

Low AT resolved 5 years ago

KIOVIG 100 mg/ml Infusionslösung (Infusionslösung)

Parallel export of KIOVIG 100 mg/ml infusion solution is banned due to active ingredient shortages. The product is not available for domestic patient needs despite being marketable.